Delivery Order SPE2DB22D6029-SPE2DB25FLVEB
- Not listed
- The Defense Logistics Agency awarded a $1,887.94 delivery order to AmerisourceBergen Drug Corp for the supply of Fomepizole 1.5 gm/1.5 ml vials on July 21, 2025, with an ultimate completion date of July 22, 2025. The award is structured as a firm fixed-price contract with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on May 30, 2025, by the Defense Logistics Agency for the supply of Fomepizole 1.5 GM/1.5 ML vials. The contract is valued at $4,666.83 with a firm fixed price and carries a completion date of June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fomepizole 1.5 GM/1.5 ML vials. The $2,887.34 firm-fixed-price contract has an ultimate completion date of July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $2,252.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 1.5 gram/1.5 milliliter vials of the drug fomepizole. This single award contract has a completion date of February 8, 2024 and does not include any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a...
- The Defense Logistics Agency Troop Support Medical awarded a $321.79 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4561879909, 1.5 grams/1.5 milliliter vials of fomepizole. Performance will take place in Conshohocken, Pennsylvania. The single day order from August 21st to August 22nd, 2023 is being fulfilled under an existing indefinite delivery/indefinite quantity contract vehicle held by Amerisourcebergen Corporation, the parent company of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,194.02 on July 9, 2025, for the supply of Phenohytro Elixir 120ml to support federal medical procurement needs. The contract utilizes firm fixed-price pricing with an ultimate completion date of July 10, 2025, and was competitively awarded without set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,609.77 to AmerisourceBergen Drug Corp on July 23, 2025, under a firm fixed price contract. This delivery order, which is part of a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX, valued at $999,999,999.00 through December 2026), represents a single transaction fulfilling pharmaceutical and medical supply requirements. The award was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,247.28 to AmerisourceBergen Drug Corp on April 10, 2025, with ultimate completion scheduled for April 11, 2025. This firm fixed-price delivery order, issued under a non-competed contract vehicle, represents a continuation of pharmaceutical and medical supply procurement to support federal healthcare operations. The work will be performed at the contractor's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,756.24 by the Defense Logistics Agency's Medical Supply Chain on September 18, 2025. The contract, which represents a child order under a larger indefinite delivery vehicle, involves firm fixed pricing with no set-aside designation and an ultimate completion date of September 19, 2025. As a critical vendor for federal medical procurement,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,020.92 by the Defense Logistics Agency's Medical Supply Chain on September 30, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, is set to be completed by October 1, 2025, with performance taking place at the awardee's Conshohocken facility. The award was made through competitive...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVEBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,699.04 to AmerisourceBergen Drug Corp for the supply of Fomepizole 1.5 gm/1.5 ml vials. The contract, awarded on May 30, 2025, with completion targeted for June 2, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive procurement. Performance will occur at AmerisourceBergen's Conshohocken, Pennsylvania facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. As the prime contractor on the SPE2DX IDC, the company supplies a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare systems. The Fomepizole delivery represents a component of the company's extensive portfolio fulfilling federal medical supply requirements through its global pharmaceutical support vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/30/25 |